Gefitinib

• Post Date:

  Feb 04,2015

• Expiry Date:

  Feb 04,2016

• Detailed Description:

  Cas No. :184475-35-2 Product name: Gefitinib
  CAS: 184475-35-2
  Molecular formula: C22H24ClFN4O3
  Molecular weight: 446.9
  Description: Gefitinib (trade name Iressa, marketed by AstraZeneca and Teva), is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR.

• CAS Registry Number:

  184475-35-2

• Synonyms:

  ;GEFITINIB;AKOS 91371;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;Gefitinib(TINIBS);Gefitinib, Iressa, ZD1839;Gefitinib Base;Geftinib;

• Molecular Formula:

  C₂₂H₂₄ClFN₄O₃

• Molecular Weight:

  446.9024

• Molecular Structure:

  

• Company:

  AUSMAUCO BIOTECH CO., LIMITED     [ China ]        

• Contact:

  john

• Tel:

  +8618060810639

• Fax:

• Email:

  plantsale@aus-bio.com